Neuropsychotherapeutics
Academic Press Inc (Verlag)
978-0-12-816668-0 (ISBN)
Jeffrey M. Witkin, Witkin Consulting Group, IN, USA
1. GPCR drug discovery-moving beyond the orthosteric to the allosteric domainChristian C. Felder2. Lipid rafts in psychiatryNathan H. Wray and Mark M. Rasenick3. Rapid-acting antidepressantsJeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu and Jodi L. Smith4. mGlu2/3 receptor antagonistsShigeyuki Chaki5. Nitric oxide: Antidepressant mechanisms and inflammationMehdi Ghasemi6. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disordersLaura B. Teal, Robert W. Gould, Andrew S. Felts and Carrie K. Jones7. Medications development for food-based and drug use disordersFernando B. de Moura, Stephen J. Kohut and Jack Bergman8. Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic researchErik Z. Woody, Kurt Leroy Hoffman and Henry Szechtman9. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disordersKjell A. Svensson, Junliang Hao and Robert F. Bruns
| Erscheinungsdatum | 09.08.2019 |
|---|---|
| Reihe/Serie | Advances in Pharmacology |
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 700 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| ISBN-10 | 0-12-816668-1 / 0128166681 |
| ISBN-13 | 978-0-12-816668-0 / 9780128166680 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich